Product Information
DCZ0415 is a histone deacetylase (HDAC) inhibitor. It is used for the treatment of cancer by inducing cell differentiation and inhibiting tumor growth. DCZ0415 has been shown to be effective in a number of animal models, including those with prostate cancer, breast cancer, and colon cancer. This drug has also been shown to be effective in treating malignant cancers in humans, such as lung and pancreatic cancers. DCZ0415 inhibits HDAC activity at the transcriptional level and has been shown to have anti-inflammatory effects.
Chemical properties
Technical inquiry about: 3D-SPD47043 DCZ0415
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
